Neuro, Yes, that sounds right. They're still analyzing, but they've seen enough positive indications to feel comfortable presenting the results at the conference. That's a good enough signal for me. To the moon baby :o)
Since this may be Stoll’s last hurrah, he wants to leave with style. What better way than to present strong evidence of efficacy? Even if COR has all the data it needs for a pr release right now, who is going to complain if it is delayed by a few days? An excuse can always be made if there is a complaint to the SEC. But, come on, who would?
Market Data 
Markets 
AI
